Company profile · Warsaw, Poland

Scope Fluidics

Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics · Diagnostics platform

Scope Fluidics runs microfluidic diagnostics development, point-of-care platform development, and amr diagnostics programs in Warsaw, Poland.

Lead
Piotr Garstecki (verified ↗)
Address
Ogrodowa 58, 9th floor, 00-876 Warsaw, Poland (source ↗)
Compliance
Not yet on record
Last reviewed
22 Mar 2026 (2mo ago)
Scale
Diagnostics platform
Capabilities
Microfluidic Diagnostics Development · Point-of-Care Platform Development · AMR Diagnostics Programs
Founded
2010
Headcount
51-200
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Piotr Garstecki

President of the Management Board

Check official leadership source
Full addressOgrodowa 58, 9th floor, 00-876 Warsaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Scope Fluidics page listing the Warsaw headquarters address.

Open source
Operating profile

Diagnostics platform

Warsaw, Poland. Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics. Review completed on 22 Mar 2026.

2026 technical specializationDiagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics
Core capabilities
Microfluidic Diagnostics DevelopmentPoint-of-Care Platform DevelopmentAMR Diagnostics Programs
Governance

Polish diagnostics and medtech oversight

Official leadership disclosure, Official Warsaw address disclosure, Diagnostics platform claim

Editorial note

Diagnostics, Microfluidics, Point-of-Care, Antimicrobial Resistance, and Molecular Diagnostics

Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.

Editorial note

Scope Fluidics is published because official company materials confirm current leadership, Warsaw operating address, and a real diagnostics innovation platform.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 22 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Microfluidic Diagnostics Development
Point-of-Care Platform Development
AMR Diagnostics Programs
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial Scope Fluidics investor materials naming Piotr Garstecki as President of the Management Board.Source origin: ir.scopefluidics.comOpen source
Supporting evidenceOfficial Scope Fluidics page confirming the Warsaw headquarters address.Source origin: scopefluidics.comOpen source
Physical-site evidenceOfficial Scope Fluidics page listing the Warsaw headquarters address.Source origin: scopefluidics.comOpen source
Infrastructure

Declared infrastructure

Microfluidics development workflow
Diagnostics R&D systems
Program and corporate infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Scope Fluidics located?
Scope Fluidics operates from Ogrodowa 58, 9th floor, 00-876 Warsaw, Poland, Warsaw, Poland.
Who runs Scope Fluidics?
Scope Fluidics is led by Piotr Garstecki, President of the Management Board. Verified 22 Mar 2026.
What does Scope Fluidics do?
Scope Fluidics runs microfluidic diagnostics development, point-of-care platform development, and amr diagnostics programs in Warsaw, Poland. Core capabilities: Microfluidic Diagnostics Development, Point-of-Care Platform Development, AMR Diagnostics Programs.
Editorial context

Related technical briefs

Briefs that name Warsaw as a covered market or city.